4D Molecular Therapeutics, Inc. Share Price
Stocks
FDMT
US35104E1001
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
20:00:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 12.93 USD | +8.11% |
|
-1.30% | +72.40% |
| 10-21 | 4D Molecular Therapeutics, Inc. - Analyst/Investor Day | |
| 10-07 | 4D Molecular Therapeutics Insider Sold Shares Worth $753,937, According to a Recent SEC Filing | MT |
| Market Cap | 714M 640M 591M 536M 999M 68.01B 1.01B 7.08B 2.82B 35.59B 2.68B 2.62B 113B | P/E 2026 * |
-3.12x | P/E 2027 * | -3.23x |
|---|---|---|---|---|---|
| Enterprise Value | 519M 465M 430M 390M 726M 49.43B 736M 5.14B 2.05B 25.87B 1.95B 1.91B 81.92B | EV / Sales 2026 * |
39.2x | EV / Sales 2027 * | 18.4x |
| Free-Float |
97.28% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| FDMT | Delayed | |
CBOE
| FDMT | Real-time |
Last Transcript: 4D Molecular Therapeutics, Inc.
| 1 day | +8.11% | ||
| 1 week | -1.30% | ||
| Current month | -9.64% | ||
| 1 month | -10.64% | ||
| 3 months | +24.57% | ||
| 6 months | +36.83% | ||
| Current year | +72.40% |
| 1 week | 10.62 |  | 13.12 |
| 1 month | 10.62 | | 14.97 |
| Current year | 6.96 | | 16.93 |
| 1 year | 6.96 | | 16.93 |
| 3 years | 2.24 | | 36.25 |
| 5 years | 2.24 | | 36.25 |
| 10 years | 2.24 | | 55.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theresa Janke
COO | Chief Operating Officer | 51 | 31/03/2018 |
David Kirn
CEO | Chief Executive Officer | 64 | 11/09/2013 |
Kristian Humer
DFI | Director of Finance/CFO | 51 | 16/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Kirn
CHM | Chairman | 64 | 11/09/2013 |
Charles Theuer
BRD | Director/Board Member | 62 | 30/11/2015 |
Jacob Chacko
BRD | Director/Board Member | 47 | 28/02/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/10/26 | Sell | Founder | -58,333 | 0.1056% | ||
| 16/09/26 | Exercice | Compliance Officer | 4,905 | 0.0089% | ||
| 14/09/26 | Sell | Founder | -58,333 | 0.1056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.11% | -1.30% | +5.38% | +23.50% | 661M | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.76% | +2.10% | +12.10% | +81.21% | 54.55B | |
| -0.94% | +0.77% | +8.85% | +100.19% | 53.59B | |
| +2.76% | +4.18% | +28.34% | +55.07% | 44.75B | |
| +2.00% | -2.90% | +18.37% | +119.04% | 41.62B | |
| +1.34% | -3.98% | +225.44% | +914.08% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +48.65% | +106.84% | +92.73% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +4.91% | -1.25% | +47.48% | +148.89% | 38.11B | |
| Weighted average by Cap. | +3.24% | -0.30% | +47.49% | +161.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.26M 11.88M 10.98M 9.95M 18.55M 1.26B 18.8M 131M 52.31M 661M 49.73M 48.69M 2.09B | 20.63M 18.5M 17.08M 15.49M 28.87M 1.96B 29.27M 204M 81.43M 1.03B 77.4M 75.78M 3.26B |
| Net income | -289M -259M -239M -217M -404M -27.48B -409M -2.86B -1.14B -14.38B -1.08B -1.06B -45.54B | -316M -284M -262M -237M -442M -30.11B -449M -3.13B -1.25B -15.76B -1.19B -1.16B -49.9B |
| Net Debt | -195M -175M -162M -146M -273M -18.58B -277M -1.93B -770M -9.72B -732M -717M -30.79B | -334M -300M -277M -251M -467M -31.81B -474M -3.31B -1.32B -16.65B -1.25B -1.23B -52.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | US$12.93 | +8.11% | 1,188,605 |
| 27/10/26 | US$11.96 | +8.43% | 1,134,654 |
| 26/10/26 | US$11.03 | +2.13% | 1,084,578 |
| 23/10/26 | US$10.80 | -8.86% | 996,140 |
| 22/10/26 | US$11.85 | -6.10% | 1,354,686 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FDMT Stock
Select your edition
All financial news and data tailored to specific country editions
